Sunhawk Vision Biotech Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Selling, General & Admin	23.23	24.03	25.02	26.03
Research & Development	126.92	151.34	76.13	87.04
Operating Expenses	150.15	175.37	101.15	113.07
Operating Income	-150.15	-175.37	-101.15	-113.07
Interest Expense	-0.14	-0.18	-0.19	-0.02
Interest & Investment Income	8.03	8.72	4.32	1.71
Currency Exchange Gain (Loss)	-4.35	-4.35	4.11	-4.46
Other Non Operating Income (Expenses)	16.02	0.02	6.46	17.94
EBT Excluding Unusual Items	-130.59	-171.16	-86.45	-97.9
Gain (Loss) on Sale of Investments	-1	-1	-	-
Gain (Loss) on Sale of Assets	-0.26	-0.26	-0.68	-
Other Unusual Items	0.04	0.04	0.01	-
Pretax Income	-131.82	-172.39	-87.13	-97.9
Income Tax Expense	-	-	0.09	-0.03
Earnings From Continuing Operations	-131.82	-172.39	-87.22	-97.88
Minority Interest in Earnings	-	-	-0.64	72.78
Net Income	-131.82	-172.39	-87.85	-25.1
Preferred Dividends & Other Adjustments	-	-	-0.64	72.78
Net Income to Common	-131.82	-172.39	-87.22	-97.88
Net Income Growth	-	-	-	-
Shares Outstanding (Basic)	70	70	62	62
Shares Outstanding (Diluted)	70	70	62	62
Shares Change	5.17%	12.09%	0.92%	-
EPS (Basic)	-1.89	-2.47	-1.40	-1.59
EPS (Diluted)	-1.89	-2.47	-1.40	-1.59
EPS Growth	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Free Cash Flow	-105.95	-145.31	-96.06	-78.24
Free Cash Flow Per Share	-1.52	-2.08	-1.54	-1.27
EBITDA	-148.37	-173.87	-99.6	-112.33
D&A For EBITDA	1.78	1.49	1.55	0.75
EBIT	-150.15	-175.37	-101.15	-113.07